This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Cornelia de Lange syndrome | |
|---|---|
| Name | Cornelia de Lange syndrome |
| Field | Medical genetics, Pediatrics |
| Onset | Congenital |
| Causes | Genetic variants |
| Diagnosis | Clinical evaluation, genetic testing |
| Treatment | Supportive care, therapies |
| Frequency | Rare |
Cornelia de Lange syndrome is a congenital multisystem condition characterized by distinctive craniofacial features, growth restriction, limb anomalies, and neurodevelopmental differences. It presents in neonates and children with variable severity, often requiring multidisciplinary care from specialists in Great Ormond Street Hospital, Johns Hopkins Hospital, Mayo Clinic, Massachusetts General Hospital, and regional pediatric centers such as Sheffield Children's Hospital and Royal Children's Hospital. Patients frequently interface with services including American Academy of Pediatrics, European Society of Human Genetics, National Health Service, Centers for Disease Control and Prevention, and advocacy groups like Cornelia de Lange Syndrome Foundation.
Affected individuals commonly show characteristic facial morphology, growth deficiency, microcephaly, and limb differences. Typical craniofacial signs are thin arched eyebrows, long eyelashes, low anterior hairline, synophrys, short upturned nose, small widely spaced teeth, and micrognathia noted during assessment by teams at Stanford Children's Health, Children's Hospital of Philadelphia, Cincinnati Children's Hospital Medical Center, Boston Children's Hospital, and Texas Children's Hospital. Developmental features include global developmental delay, intellectual disability, autism spectrum disorder traits, and communication impairments managed by speech therapists from Royal College of Speech and Language Therapists and behavioral teams from Autism Speaks, Child Mind Institute, and National Autistic Society. Gastrointestinal problems such as gastroesophageal reflux, feeding difficulties, and constipation are common, prompting involvement of specialists from American Gastroenterological Association and centers like Hôpital Necker-Enfants Malades. Cardiac defects including ventricular septal defects and atrial septal defects occur, requiring evaluation by cardiology services at Royal Brompton Hospital and The Heart Hospital. Sensory issues include hearing loss and vision problems managed by audiology and ophthalmology units at Moorfields Eye Hospital and Guy's and St Thomas' NHS Foundation Trust.
The syndrome results from pathogenic variants affecting cohesion and chromatin regulatory genes, most notably NIPBL, SMC1A, SMC3, RAD21, and HDAC8, discovered through collaborative research at institutions including Wellcome Sanger Institute, Broad Institute, University of Cambridge, Karolinska Institutet, and University of Washington. Molecular mechanisms implicate defective cohesin complex function, dysregulated transcriptional programs, and altered developmental gene expression during embryogenesis studied by groups at Howard Hughes Medical Institute, Max Planck Institute for Molecular Genetics, Cold Spring Harbor Laboratory, and Francis Crick Institute. Genetic inheritance is commonly autosomal dominant with de novo variants, X-linked patterns for SMC1A and HDAC8, and mosaicism reported in cohorts from King's College London, Hôpital Necker-Enfants Malades, and Johns Hopkins University School of Medicine. Functional studies employing zebrafish, mouse, and Drosophila models have been published by teams at University of California, San Francisco, National Institutes of Health, University of Toronto, and McGill University.
Clinical diagnosis integrates dysmorphology assessment, growth measurements, neurodevelopmental evaluation, and targeted genetic testing. Diagnostic confirmation uses sequencing and copy-number analysis performed by laboratories at Invitae, GeneDx, Ambry Genetics, Clinical Genomics Laboratory at Baylor College of Medicine, and research units at Wellcome Trust Sanger Institute. Standardized diagnostic criteria and scoring systems have been published and refined by consortia including European Reference Network, International Genetic Epidemiology Society, American College of Medical Genetics and Genomics, and multidisciplinary teams from Great Ormond Street Hospital and Boston Children's Hospital. Prenatal diagnosis is possible via invasive testing or cell-free DNA analysis coordinated through fetal medicine centers like Fetal Medicine Unit, King's College Hospital and Mount Sinai Medical Center.
There is no cure; treatment is symptomatic and multidisciplinary, involving pediatricians, geneticists, cardiologists, gastroenterologists, surgeons, speech and occupational therapists, orthopedic teams, and educational specialists. Interventions include nutritional support and gastrostomy from surgical services at Great Ormond Street Hospital, cardiac repair at Royal Brompton Hospital, ENT management by teams at Guy's and St Thomas' NHS Foundation Trust, and tailored education plans in collaboration with agencies such as Department for Education, Individuals with Disabilities Education Act, and local school districts. Pharmacologic management addresses seizures, behavior, and reflux guided by formularies like British National Formulary and American Society of Health-System Pharmacists. Support networks and transition services are provided by charities including Cornelia de Lange Syndrome Foundation, Genetic Alliance, Rare Diseases UK, and patient advocacy groups operating with international partners like World Health Organization.
Prognosis varies by severity of congenital anomalies, cardiac and respiratory complications, feeding issues, and neurological involvement. Life expectancy can be near-normal in mild cases but reduced when severe airway, cardiac, or gastrointestinal complications occur; outcomes have been reported from longitudinal cohorts at Boston Children's Hospital, Nationwide Children's Hospital, Royal Children's Hospital Melbourne, and The Hospital for Sick Children (SickKids). Common complications include recurrent respiratory infections, aspiration, growth failure, orthopedic deformities, and behavioral challenges managed by multidisciplinary clinics at institutions such as University College London Hospitals and Evelina London Children's Hospital.
Estimated prevalence ranges roughly from 1 in 10,000 to 1 in 30,000 live births based on registry data compiled by national surveillance systems in United States, United Kingdom, France, Netherlands, Australia, and population studies by groups at Centers for Disease Control and Prevention, Office for National Statistics, and research networks including European Society of Human Genetics. Epidemiologic variation reflects ascertainment differences, diagnostic criteria, and access to genetic testing in regions served by laboratories like Mayo Clinic Laboratories and ARUP Laboratories.
The condition was first characterized in case reports during the early 20th century and later delineated clinically and genetically through work by clinicians and researchers at Great Ormond Street Hospital, Boston Children's Hospital, Utrecht University Medical Center, Erasmus MC, and geneticists associated with University of Leiden and University of Groningen. Social and educational inclusion efforts involve partnerships among UNICEF, Special Olympics, ILO, and national disability organizations such as Disability Rights UK and American Association on Intellectual and Developmental Disabilities. Cultural representations and media coverage have appeared in outlets like BBC News, The New York Times, The Guardian, National Geographic, and documentary features produced by PBS and Channel 4.
Category:Genetic disorders